Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial

Fausto Petrelli, Roberto Labianca, Alberto Zaniboni, Sara Lonardi, Fabio Galli, Eliana Rulli, Gerardo Rosati, Salvatore Corallo, Monica Ronzoni, Giovanni Gerardo Cardellino, Rodolfo Mattioli, Andrea Mambrini, Libero Ciuffreda, Maria Banzi, Valeria Pusceddu, Evaristo Maiello, Maria Zampino, Vittorina Zagonel, Paolo Marchetti, Domenico CorsiLorenza Rimassa, Saverio Cinieri, Alberto Sobrero

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences